1311385-32-6

Basic information

• Product Name: MGlu2 agonist
• Synonyms: MGlu2 agonist;Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-[[(2S)-2-aMino-1-oxopropyl]aMino]-4-(1H-1,2,4-triazol-5-ylthio)-, aMMoniuM salt, hydrate (1:1:1), (1R,2S,4R,5R,6R)-;(1R,2S,4R,5R,6R)-2-[[(2S)-2-Amino-1-oxopropyl]amino]-4-(1H-1,2,4-triazol-5-ylthio)-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid ammonium salt hydrate (1:1:1);(1R,2S,4R,5R,6R)-2-[[(2S)-2-Amino-1-oxopropyl]amino]-4-(1H-1,2,4-triazol-5-ylthio)-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid ammonium salt hydrate (1:1:1) LY2979165;LY2979165 Ammonium salt
• CAS NO: 1311385-32-6
• Molecular Formula: C13H22N6O6S
• Molecular Weight: 390.41538
• Mol File: 1311385-32-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: MGlu2 agonist(CAS DataBase Reference)
• NIST Chemistry Reference: MGlu2 agonist(1311385-32-6)
• EPA Substance Registry System: MGlu2 agonist(1311385-32-6)

Safety Data

• Hazardous Substances Data: 1311385-32-6(Hazardous Substances Data)

Usage

General Description

mGlu2 agonist is a type of chemical compound that activates the metabotropic glutamate receptor 2 (mGlu2), a G protein-coupled receptor found in the central nervous system. By binding to and activating mGlu2, these compounds produce a series of signaling events that result in the modulation of glutamate neurotransmission. This can lead to the inhibition of excessive glutamate release, which is thought to be involved in various psychiatric and neurological disorders such as schizophrenia, depression, and anxiety. Therefore, mGlu2 agonists are being studied as potential therapeutic agents for these conditions, with the goal of restoring the balance of glutamatergic transmission in the brain.